Log in

LON:SPESopheon Share Price, Forecast & News

GBX 775
0.00 (0.00 %)
(As of 07/16/2020 08:44 AM ET)
Add
Compare
Today's Range
790
Now: GBX 775
790
50-Day Range
684
MA: GBX 725.90
776
52-Week Range
383.55
Now: GBX 775
1,029.20
Volume245 shs
Average Volume27,251 shs
Market Capitalization£79.07 million
P/E Ratio40.36
Dividend Yield0.42%
BetaN/A
Sopheon plc designs, develops, and markets software products with associated implementation and consultancy services in North America and Europe. The company's software products comprise Accolade, Accolade Express, Accolade Cloud, Accolade Go, Accolade Integration, and Accolade Accelerators. Its solutions provide support for innovation planning, road mapping, idea and concept development, process and project management, portfolio management and optimization, and resource planning, as well as analytics, collaborative workflow, product lifecycle management, and stage-gate automation. The company also offers services, such as assessments, consulting, implementation, training, and support; and maintenance, hosting, and cloud services, as well as software as a service. It serves customers in the aerospace and defense, automotive, chemical and coatings, consumer goods, food and beverage, high tech, industrial, and other sectors. The company was formerly known as PolyDoc and changed its name to Sopheon plc in 1999. Sopheon plc was founded in 1993 and is based in West End, the United Kingdom.
Read More
Sopheon logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.0Community Rank: 2.1Dividend Strength: 0.8Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.11 out of 5 stars


Industry, Sector and Symbol

Industry Technical & System Software
Sub-IndustryN/A
CUSIPN/A
CIKN/A
Phone+44-1276-919560

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£30.25 million
Cash FlowGBX 191 per share
Book ValueGBX 274.20 per share

Profitability

Miscellaneous

Employees147
Market Cap£79.07 million
Next Earnings DateN/A
OptionableNot Optionable

Receive SPE News and Ratings via Email

Sign-up to receive the latest news and ratings for SPE and its competitors with MarketBeat's FREE daily newsletter.

Sopheon (LON:SPE) Frequently Asked Questions

How has Sopheon's stock been impacted by COVID-19 (Coronavirus)?

Sopheon's stock was trading at GBX 680 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, SPE shares have increased by 14.0% and is now trading at GBX 775. View which stocks have been most impacted by Coronavirus.

How often does Sopheon pay dividends? What is the dividend yield for Sopheon?

Sopheon declared a dividend on Thursday, March 19th. Investors of record on Thursday, June 11th will be given a dividend of GBX 3.25 per share on Friday, July 10th. This represents a dividend yield of 0.65%. The ex-dividend date of this dividend is Thursday, June 11th. The official announcement can be viewed at this link. View Sopheon's dividend history.

What price target have analysts set for SPE?

0 brokers have issued twelve-month target prices for Sopheon's stock. Their forecasts range from GBX 1,425 to GBX 1,425. On average, they anticipate Sopheon's stock price to reach GBX 1,425 in the next twelve months. This suggests a possible upside of 83.9% from the stock's current price. View analysts' price targets for Sopheon.

Has Sopheon been receiving favorable news coverage?

Media coverage about SPE stock has been trending positive this week, InfoTrie Sentiment reports. The research group identifies negative and positive press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Sopheon earned a coverage optimism score of 2.1 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the company's share price in the next few days. View the latest news about Sopheon.

Who are some of Sopheon's key competitors?

What other stocks do shareholders of Sopheon own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sopheon investors own include GALAPAGOS NV/S (GLPG), Pharming Group (PHGUF), Kratos Defense & Security Solutions (KTOS), Myokardia (MYOK), Laboratory Corp. of America (LH), NVR (NVR), Pacira Biosciences (PCRX), Southern (SO), Bango (BGO) and Altitude Group (ALT).

Who are Sopheon's key executives?

Sopheon's management team includes the following people:
  • Mr. Barry K. Mence, Exec. Chairman (Age 66)
  • Mr. Andrew Lloyd Michuda, CEO & Exec. Director (Age 64)
  • Mr. Arif Karimjee ACA, CFO, Fin. Director, Sec. & Exec. Director (Age 52)
  • Mr. Paul Heller, Chief Technology Officer
  • Mr. Ronald Helgeson, VP of Corp. Communications

What is Sopheon's stock symbol?

Sopheon trades on the London Stock Exchange (LON) under the ticker symbol "SPE."

How do I buy shares of Sopheon?

Shares of SPE and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Sopheon's stock price today?

One share of SPE stock can currently be purchased for approximately GBX 775.

How big of a company is Sopheon?

Sopheon has a market capitalization of £79.07 million and generates £30.25 million in revenue each year. Sopheon employs 147 workers across the globe.

What is Sopheon's official website?

The official website for Sopheon is www.sopheon.com.

How can I contact Sopheon?

Sopheon's mailing address is Dorna House One, Guildford Road, WOKING, GU24 9PW, United Kingdom. The company can be reached via phone at +44-1276-919560.

This page was last updated on 7/16/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.